New COVID-19 skin manifestations continue to be described. We present a patient with COVID-19 related anagen effluvium. The patient was treated with and responded to low dose systemic steroids to treat an accompanying extensive COVID-19-related urticaria and maculopapular rash.
CITATION STYLE
Shanshal, M. (2020). COVID-19 related anagen effluvium. Journal of Dermatological Treatment, 1–2. https://doi.org/10.1080/09546634.2020.1792400
Mendeley helps you to discover research relevant for your work.